Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
CLB Stock Forecast 2026-2027
$16.61
Current Price
$773.42M
Market Cap
Buy 1
Hold 1
Sell 1
Wall St Analyst Ratings
Distance to CLB Price Targets
+32.5%
To High Target of $22.00
-9.7%
To Median Target of $15.00
-30.8%
To Low Target of $11.50
CLB Price Momentum
+1.7%
1 Week Change
+1.7%
1 Month Change
+39.7%
1 Year Change
+3.6%
Year-to-Date Change
-18.4%
From 52W High of $20.36
+70.9%
From 52W Low of $9.72
📊 TOP ANALYST CALLS
Did CLB Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Core Labs is one of their latest high-conviction picks.
Latest CLB Stock Price Targets & Analyst Predictions
Based on our analysis of 12 Wall Street analysts, CLB has a neutral consensus with a median price target of $15.00 (ranging from $11.50 to $22.00). The overall analyst rating is Buy (6.0/10). Currently trading at $16.61, the median forecast implies a -9.7% downside. This outlook is supported by 1 Buy, 1 Hold, and 1 Sell ratings.
The most optimistic forecast comes from Stephen Gengaro at Stifel, projecting a 32.5% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CLB Analyst Ratings
1
Buy
1
Hold
1
Sell
CLB Price Target Range
Low
$11.50
Average
$15.00
High
$22.00
Current: $16.61
Latest CLB Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CLB.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jul 16, 2025 | Stifel | Stephen Gengaro | Hold | Maintains | $12.00 |
| May 13, 2025 | Citigroup | Scott Gruber | Neutral | Maintains | $13.00 |
| Apr 15, 2025 | Stifel | Stephen Gengaro | Hold | Maintains | $15.00 |
| Mar 12, 2025 | Citigroup | Scott Gruber | Neutral | Upgrade | $16.00 |
| Feb 20, 2025 | Citigroup | Scott Gruber | Sell | Maintains | $15.00 |
| Oct 31, 2024 | Citigroup | Scott Gruber | Sell | Maintains | $14.00 |
| Jul 26, 2024 | Stifel | Stephen Gengaro | Hold | Maintains | $22.00 |
| Jul 15, 2024 | B of A Securities | Chase Mulvehill | Underperform | Maintains | $15.00 |
| Jul 15, 2024 | Piper Sandler | Luke Lemoine | Neutral | Maintains | $17.00 |
| Apr 26, 2024 | Stifel | Stephen Gengaro | Hold | Maintains | $18.00 |
| Apr 15, 2024 | B of A Securities | Chase Mulvehill | Underperform | Maintains | $16.00 |
| Feb 5, 2024 | Stifel | Stephen Gengaro | Hold | Maintains | $17.00 |
| Jan 29, 2024 | Stifel | Stephen Gengaro | Hold | Maintains | $21.00 |
| Sep 18, 2023 | Citigroup | Scott Gruber | Sell | Maintains | $20.00 |
| Jul 31, 2023 | Piper Sandler | Luke Lemoine | Neutral | Maintains | $21.00 |
| Jun 30, 2023 | Citigroup | Scott Gruber | Sell | Downgrade | $21.00 |
| May 1, 2023 | Piper Sandler | Luke Lemoine | Neutral | Maintains | $19.00 |
| Apr 28, 2023 | Stifel | Stephen Gengaro | Hold | Maintains | $25.00 |
| Apr 18, 2023 | B of A Securities | Chase Mulvehill | Underperform | Downgrade | $21.50 |
| Feb 7, 2023 | Citigroup | Scott Gruber | Neutral | Maintains | $26.00 |
Core Laboratories Inc. (CLB) Competitors
The following stocks are similar to Core Labs based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Core Laboratories Inc. (CLB) Financial Data
Core Laboratories Inc. has a market capitalization of $773.42M with a P/E ratio of 27.4x. The company generates $526.52M in trailing twelve-month revenue with a 5.6% profit margin.
Revenue growth is +7.0% quarter-over-quarter, while maintaining an operating margin of +10.9% and return on equity of +11.6%.
Valuation Metrics
Market Cap
$773.42M
Enterprise Value
$912.44M
P/E Ratio
27.4x
PEG Ratio
22.7x
Price/Sales
1.5x
Growth & Margins
Revenue Growth (YoY)
+7.0%
Gross Margin
+18.1%
Operating Margin
+10.9%
Net Margin
+5.6%
EPS Growth
-33.2%
Financial Health
Cash/Price Ratio
+3.0%
Current Ratio
2.0x
Debt/Equity
60.3x
ROE
+11.6%
ROA
+5.5%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Core Laboratories Inc. (CLB) Business Model
About Core Laboratories Inc.
What They Do
Provides reservoir services to the oil and gas industry.
Business Model
The company generates revenue by offering specialized services such as fluid analysis, PVT testing, and core analysis to oil and gas companies. By optimizing production capabilities and enhancing recovery techniques, it helps clients maximize the efficiency of their hydrocarbon extraction.
Additional Information
Core Laboratories is headquartered in Amsterdam and operates in key energy-producing regions globally. The company is committed to innovation and sustainability, playing a crucial role in helping energy producers navigate the challenges posed by a changing energy landscape.
Company Information
Sector
Energy
Industry
Oil & Gas Equipment & Services
Employees
3,300
CEO
Mr. Lawrence V. Bruno
Country
United States
IPO Year
1995
Website
www.corelab.comCore Laboratories Inc. (CLB) Latest News & Analysis
Latest News
Quick Summary
Investors are comparing Drilling Tools International Corp. (DTI) and Core Laboratories (CLB) for value opportunities in the Oil and Gas - Field Services sector.
Why It Matters
The comparison of DTI and CLB highlights potential investment opportunities in the Oil and Gas - Field Services sector, influencing stock selection and valuation strategies.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Core Laboratories Inc. (NYSE: CLB) is monitoring the geopolitical conflict in the Middle East and its potential impact on Q1 2026 results, prioritizing employee safety and project execution.
Why It Matters
Geopolitical instability in the Middle East could disrupt Core Laboratories’ operations and financial performance, impacting investor confidence and stock performance.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
CLB benefits from offshore growth, high-margin services, and innovation, but faces challenges from geopolitical tensions, weak U.S. markets, and uncertain oil prices.
Why It Matters
CLB's growth potential from offshore expansion and innovation is countered by geopolitical risks, weak U.S. demand, and volatile oil prices, impacting profitability and investment stability.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Quick Summary
CLB has cut its Q1 2026 guidance due to ongoing geopolitical tensions, which are disrupting operations and causing supply chain issues and reduced client activity.
Why It Matters
CLB's reduced Q1 2026 guidance signals potential revenue decline and operational challenges, impacting investor confidence and stock performance amid ongoing geopolitical tensions.
Source: Zacks Investment Research
Market Sentiment:
Negative
Quick Summary
Investors are evaluating Drilling Tools International Corp. (DTI) and Core Laboratories (CLB) for potential value opportunities in the Oil and Gas - Field Services sector.
Why It Matters
The comparison of DTI and CLB indicates potential investment opportunities, guiding portfolio decisions in the Oil and Gas sector based on value assessments.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Core Laboratories (CLB) reported earnings 30 days ago; investors should monitor upcoming developments for potential impacts on the stock.
Why It Matters
Core Laboratories' recent earnings report may influence stock performance, guiding investor sentiment and expectations for future growth and market trends in the oil and gas sector.
Source: Zacks Investment Research
Market Sentiment:
Negative
Frequently Asked Questions About CLB Stock
What is Core Laboratories Inc.'s (CLB) stock forecast for 2026?
Based on our analysis of 12 Wall Street analysts, Core Laboratories Inc. (CLB) has a median price target of $15.00. The highest price target is $22.00 and the lowest is $11.50.
Is CLB stock a good investment in 2026?
According to current analyst ratings, CLB has 1 Buy ratings, 1 Hold ratings, and 1 Sell ratings. The stock is currently trading at $16.61. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CLB stock?
Wall Street analysts predict CLB stock could reach $15.00 in the next 12 months. This represents a -9.7% decrease from the current price of $16.61. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Core Laboratories Inc.'s business model?
The company generates revenue by offering specialized services such as fluid analysis, PVT testing, and core analysis to oil and gas companies. By optimizing production capabilities and enhancing recovery techniques, it helps clients maximize the efficiency of their hydrocarbon extraction.
What is the highest forecasted price for CLB Core Laboratories Inc.?
The highest price target for CLB is $22.00 from Stephen Gengaro at Stifel, which represents a 32.5% increase from the current price of $16.61.
What is the lowest forecasted price for CLB Core Laboratories Inc.?
The lowest price target for CLB is $11.50 from at , which represents a -30.8% decrease from the current price of $16.61.
What is the overall CLB consensus from analysts for Core Laboratories Inc.?
The overall analyst consensus for CLB is neutral. Out of 12 Wall Street analysts, 1 rate it as Buy, 1 as Hold, and 1 as Sell, with a median price target of $15.00.
How accurate are CLB stock price projections?
Stock price projections, including those for Core Laboratories Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 10, 2026 5:38 AM UTC